Development of sulfahydantoin derivatives as β-lactamase inhibitors

Bioorg Med Chem Lett. 2021 Mar 1:35:127781. doi: 10.1016/j.bmcl.2021.127781. Epub 2021 Jan 8.

Abstract

Sulfahydantoin-based molecules may provide a means to counteract antibiotic resistance, which is on the rise. These molecules may act as inhibitors of β-lactamase enzymes, which are key in some resistance mechanisms. In this paper, we report on the synthesis of 6 novel sulfahydantoin derivatives by the key reaction of chlorosulfonyl isocyanate to form α-amino acid derived sulfamides, and their cyclization into sulfahydantoins. The synthesis is rapid and provides the target compounds in 8 steps. We investigated their potential as β-lactamase inhibitors using two common Class A β-lactamases, TEM-1 and the prevalent extended-spectrum TEM-15. Two compounds, 3 and 6, show substantial inhibition of the β-lactamases with IC50 values between 130 and 510 μM and inferred Ki values between 32 and 55 μM.

Keywords: Antibiotic resistance; Competitive inhibitors; Non-lactam inhibitors; Sulfahydantoin; TEM-1; β-lactamase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Development*
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship
  • Sulfur Compounds / chemical synthesis
  • Sulfur Compounds / chemistry
  • Sulfur Compounds / pharmacology*
  • beta-Lactamase Inhibitors / chemical synthesis
  • beta-Lactamase Inhibitors / chemistry
  • beta-Lactamase Inhibitors / pharmacology*
  • beta-Lactamases / metabolism*

Substances

  • Sulfur Compounds
  • beta-Lactamase Inhibitors
  • beta-Lactamases